Company Filing History:

14 out of 1,037

Japan Tobacco Inc.

4. 1 out of 832,680

Other

patents

Years Active: 2000-2013

where 'Filed Patents' based on already Granted Patents

17 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 8389690 - Antibodies to JTT-1 protein and cells secreting such antibodies (2013-03-05),

2. 7932358 - Antibodies to JTT-1 protein and cells secreting such antibodies (2011-04-26),

3. 7662781 - Immunopotentiating agent (2010-02-16),

4. 7541438 - Monoclonal antibody against connective tissue growth factor and medicinal uses thereof (2009-06-02),

5. 7294473 - Methods of identifying substances that interact with JTT-1 protein (2007-11-13),

6. 7279560 - Antibody fragments to JTT-1 protein and cells secreting such antibody fragments (2007-10-09),

7. 7259147 - Methods of treating multiple sclerosis with a JTT-1 polypeptide (2007-08-21),

8. 7247612 - Methods of treating an inflammatory disease with a JJT-1 polypeptide (2007-07-24),

9. 7226909 - Methods of inhibiting transmission of a costimulatory signal of lymphocytes (2007-06-05),

10. 7217792 - JTT-1 protein and methods of inhibiting lymphocyte activation (2007-05-15),

11. 7196175 - Antibodies to JTT-1 protein and cells secreting such antibodies (2007-03-27),

12. 7112655 - JTT-1 protein and methods of inhibiting lymphocyte activation (2006-09-26),

13. 7045615 - Nucleic acids encoding JTT-1 protein (2006-05-16),

14. 7030225 - Antibodies to JTT-1 protein, cells secreting such antibodies, and methods of making such antibodies (2006-04-18),

15. 6562618 - Monoclonal antibody against connective tissue growth factor and medicinal uses thereof (2003-05-13),

Title: Takuya Tamatani: Innovator in Autoimmune and Allergic Disease Research

Introduction

Takuya Tamatani is a prominent inventor based in Kanagawa, Japan. He has made significant contributions to the field of biomedical research, particularly in the study of autoimmune and allergic diseases. With a total of 17 patents to his name, Tamatani's work has had a profound impact on understanding and treating these conditions.

Latest Patents

Tamatani's latest patents include groundbreaking research on antibodies to the JTT-1 protein. He has isolated, identified, and analyzed novel cell surface molecules recognized by monoclonal antibodies against lymphocytic cells. These molecules play a crucial role in autoimmune and allergic diseases. Specifically, they are expressed in thymocytes, ConA-stimulated lymphocytes, and peripheral blood lymphocytes, inducing cell adhesion. The antibodies developed against these cell surface molecules have shown significant potential in ameliorating pathological conditions associated with autoimmune and allergic diseases.

Career Highlights

Throughout his career, Takuya Tamatani has worked with notable organizations, including Japan Tobacco Inc. His research has been pivotal in advancing the understanding of immune responses and developing therapeutic strategies for various diseases.

Collaborations

Tamatani has collaborated with esteemed colleagues such as Katsunari Tezuka and Shinji Sakamoto. These partnerships have further enriched his research and contributed to the success of his innovative projects.

Conclusion

Takuya Tamatani's contributions to the field of biomedical research, particularly in autoimmune and allergic diseases, highlight his role as a leading inventor. His innovative patents and collaborations continue to pave the way for advancements in medical science.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.